Search

everythinglearnresearchcommunity

for

Search:↓

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Different tests are used to see how hair care products affect hair, and choosing the right test is important for accurate results.

Hair loss may indicate higher heart risk and metabolic issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

New treatments for PCOS focus on managing symptoms and improving fertility.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.